Cargando…
EP4 Agonist L-902,688 Suppresses EndMT and Attenuates Right Ventricular Cardiac Fibrosis in Experimental Pulmonary Arterial Hypertension
Right ventricular (RV) hypertrophy is characterized by cardiac fibrosis due to endothelial–mesenchymal transition (EndMT) and increased collagen production in pulmonary arterial hypertension (PAH) patients, but the mechanisms for restoring RV function are unclear. Prostanoid agonists are effective v...
Autores principales: | Lai, Ying-Ju, Chen, I-Chen, Li, Hsin-Hsien, Huang, Chung-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877588/ https://www.ncbi.nlm.nih.gov/pubmed/29510514 http://dx.doi.org/10.3390/ijms19030727 |
Ejemplares similares
-
Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke
por: DeMars, Kelly M., et al.
Publicado: (2018) -
Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis
por: Testai, Lara, et al.
Publicado: (2021) -
To be EndMT or not to be, that is the question in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015) -
MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013) -
EndMT: New findings on the origin of myofibroblasts in endometrial fibrosis of intrauterine adhesions
por: Xu, Chengcheng, et al.
Publicado: (2022)